Concerns about Joel Embiid’s long-term health are growing across the NBA, with league insiders reportedly skeptical about his ability to stay on the floor.
According to Brett Siegel of ClutchPoints, there is “genuine concern” among teams regarding the Sixers star’s knees, despite Philadelphia continuing to downplay the issue.
Embiid, 31, played only 19 games during the 2024–25 season before undergoing surgery on his left knee in April.
This marks the second time in three years that Embiid’s season ended early due to knee complications.
He averaged 23.8 points, 8.2 rebounds, and 4.5 assists in limited action but missed the final two months of the campaign.
Philadelphia’s failure to manage its superstar’s health has raised broader questions about the organization’s direction.
Keith Pompey of The Philadelphia Inquirer said on Sirius XM NBA Radio that Embiid “may know that the end is near,” suggesting that both sides could be headed toward a split.
Pompey also pointed to dissatisfaction with the team’s culture, noting that the issues persist regardless of changes in personnel.
Despite signing a three-year, $193 million extension in 2024, Embiid’s long-term commitment to the franchise may be weakening.
He has played only 452 games across nine seasons, averaging fewer than 51 appearances per year due to recurring injuries.
The Sixers’ recent struggles have only amplified tensions, with the team finishing 23–59 and missing the playoffs entirely.
Embiid’s leadership was also called into question after a turbulent year that included a three-game suspension in November for a locker room altercation with a reporter.
That same month, teammate Tyrese Maxey criticized Embiid in a team meeting for repeated tardiness.
With Paul George also recovering from offseason knee surgery and expected to miss the start of training camp, Philadelphia’s health concerns now extend to both of its top veterans.
George, 35, appeared in just 41 games last season and has faced multiple lower-body injuries since joining the team in July.
The Sixers invested heavily in the Embiid–George–Maxey trio, but early returns have been underwhelming.
As Embiid enters his 10th NBA season, durability questions are now shaping both his future and the team’s direction.
Executives around the league are reportedly watching closely, anticipating that a major decision could come sooner than expected.
